McKesson Ventures is the corporate venture capital arm of McKesson Corporation, investing in and supporting healthcare startups that tackle challenges across the healthcare ecosystem. The firm leverages McKesson's platform, expertise, and connections to help entrepreneurs build and scale tech-enabled healthcare businesses.
59% of their portfolio is in Healthcare. Deal activity increased 400% year-over-year (5 deals in the last 12 months). Average disclosed round size is $71.3M (across 45 rounds with reported amounts).
Portfolio
36
Fund Size
—
Top Stage
Series B
Last 12 Mo
5
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
49 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 BranchLab | Seed | $26M | May 2026 |
 Latent Health | Series A | $80M | Apr 2026 |
| Latent Health | Series A | — | Mar 2026 |
 Midi | Series D | $100M | Feb 2026 |
 Prudentia Sciences | Series A | $20M | Jan 2026 |
| BranchLab | Series A | $26M | Jan 2026 |
| OOath Surgical | Series A | $24M | Jan 2025 |
 Xealth | Ipo | $50M | Jan 2025 |
 Xealth | Ipo | $50M | Jan 2025 |
 Bluenote | Series A | $10M | Dec 2024 |
 HarmonyCares | Series D | $200M | Jul 2024 |
 Atropos Health | Series B | — | May 2024 |
| AAtropos | Series B | $33M | May 2024 |
| GGRAIL, Inc. | Series B | $900M | Mar 2024 |
 RxLightning | Series A | $17.5M | Jan 2023 |
 Koneksa Health | Series C | $45M | Feb 2022 |
| EEvidation Health, Inc. | Series E | $153M | Mar 2021 |
 Aspen RxHealth | Series B | $23M | Jan 2021 |
 AllStripes | Seed | $50M | Jan 2021 |
| EEvidation Health, Inc. | Series E | $153M | Jan 2021 |
| Koneksa Health | Series B | $16M | Sep 2020 |
| EEvidation Health, Inc. | Series D | $45M | Jul 2020 |
 Matternet | Unknown | — | Jan 2020 |
 Augmedix | Series B | $19M | Oct 2019 |
| Xealth | Series A | $11M | Mar 2019 |
Page 1 of 2
Top Co-Investors
Oak HC/FT5 shared
Threshold Ventures5 shared
Novartis Venture Fund5 shared
UPMC5 shared
Providence Ventures5 shared
Sanofi Ventures4 shared
Novartis Pharma AG4 shared
B Capital4 shared
LRVHealth4 shared
Flare Capital Partners3 shared
Lux Capital3 shared
Valtruis3 shared
Emerson Collective3 shared
Sutter Health3 shared
General Catalyst3 shared
Philips Ventures3 shared
GV3 shared
Merck3 shared
Spark Capital3 shared
Last updated: 7 October 2026